These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6839959)

  • 21. Malabsorption-associated warfarin resistance.
    Sabol BJ; Basa RR; Wilkins CE
    Am J Health Syst Pharm; 2009 Sep; 66(17):1548-53. PubMed ID: 19710438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified APC-resistance test: variable ratios with respect to source of factor V-deficient plasma.
    Ts'ao C; Neofotistos D; Oropeza M; Vahabinejad S; Finn WG
    Am J Hematol; 1997 Mar; 54(3):214-8. PubMed ID: 9067500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.
    Wittkowsky AK
    Semin Vasc Med; 2003 Aug; 3(3):221-30. PubMed ID: 15199454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current concepts of warfarin therapy.
    Peterson CE; Kwaan HC
    Arch Intern Med; 1986 Mar; 146(3):581-4. PubMed ID: 3513725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary warfarin resistance.
    Diab F; Feffer S
    South Med J; 1994 Mar; 87(3):407-9. PubMed ID: 8134868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low warfarin resistance frequency in Norway rats in two cities in China after 30 years of usage of anticoagulant rodenticides.
    Ma X; Wang D; Li N; Liu L; Tian L; Luo C; Cong L; Feng Z; Liu XH; Song Y
    Pest Manag Sci; 2018 Nov; 74(11):2555-2560. PubMed ID: 29667309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Resistance to antivitamins K].
    Sánchez Villegas JM; Piqueras J; Nicolau I; Picó M; Soler JA; Monasterio J
    Sangre (Barc); 1992 Aug; 37(4):297-8. PubMed ID: 1514145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resistance to warfarin in a patient with hereditary thrombophilia].
    Haastrup P; Rudbæk T; Bove J
    Ugeskr Laeger; 2013 Oct; 175(43):2572-3. PubMed ID: 24629157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
    Dager WE
    Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative genetics of warfarin resistance.
    Oldenburg J; Müller CR; Rost S; Watzka M; Bevans CG
    Hamostaseologie; 2014; 34(2):143-59. PubMed ID: 24287886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat.
    Mosterd JJ; Thijssen HH
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS. THE FIRST REPORTED KINDRED.
    O'REILLY RA; AGGELER PM; HOAG MS; LEONG LS; KROPATKIN ML
    N Engl J Med; 1964 Oct; 271():809-15. PubMed ID: 14187664
    [No Abstract]   [Full Text] [Related]  

  • 34. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
    Raskob G; Ageno W; Cohen AT; Brekelmans MP; Grosso MA; Segers A; Meyer G; Verhamme P; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
    Lancet Haematol; 2016 May; 3(5):e228-36. PubMed ID: 27132697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
    Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warfarin resistance due to sulfasalazine.
    Teefy AM; Martin JE; Kovacs MJ
    Ann Pharmacother; 2000 Nov; 34(11):1265-8. PubMed ID: 11098339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary resistance to coumarin anticoagulant drugs in man and rat.
    O'Reilly RA; Pool JG; Aggeler PM
    Ann N Y Acad Sci; 1968 Jul; 151(2):913-31. PubMed ID: 4189970
    [No Abstract]   [Full Text] [Related]  

  • 38. Acquired warfarin resistance and weight-reducing diet.
    Qureshi GD; Reinders TP; Swint JJ; Slate MB
    Arch Intern Med; 1981 Mar; 141(4):507-9. PubMed ID: 7212893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The second reported kindred with hereditary resistance to oral anticoagulant drugs.
    O'Reilly RA
    N Engl J Med; 1970 Jun; 282(26):1448-51. PubMed ID: 4192578
    [No Abstract]   [Full Text] [Related]  

  • 40. VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.
    Azzam H; Elwakeel H; Awad I; El-Farahaty R; El-Gilany AH; El-Sharawy S
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):121-6. PubMed ID: 24978953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.